Fluorometric Detection of Low-Abundance EGFR Exon 19 Deletion Mutation Using Tandem Gene Amplification

다국어 초록 (Multilingual Abstract)

Epidermal growth factor receptor (EGFR) mutations are not only genetic markers for diagnosis but also biomarkers of clinical-response against tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC). Among the EGFR mutations, the in-frame deletion mutation in EGFR exon 19 kinase domain (EGFR exon 19-del) is the most frequent mutation, accounting for about 45% of EGFR mutations in NSCLCs. Development of sensitive method for detecting the EGFR mutation is highly required to make a better screening for drug-response in the treatment of NSCLC patients. Here, we developed a fluorometric tandem gene amplification assay for sensitive detection of lowabundance EGFR exon 19-del mutant genomic DNA. The method consists of pre-amplification with PCR, thermal cycling of ligation by Taq ligase, and subsequent rolling circle amplification (RCA). PCRamplified DNA from genomic DNA samples was used as splint DNA to conjugate both ends of linear padlock DNA, generating circular padlock DNA template for RCA. Long stretches of ssDNA harboring multiple copies of G-quadruplex structure was generated in RCA and detected by thioflavin T (ThT) fluorescence, which is specifically intercalated into the G-quadruplex, emitting strong fluorescence.
Sensitivity of tandem gene amplification assay for detection of the EGFR exon 19-del from gDNA was as low as 3.6 pg, and mutant gDNA present in the pooled normal plasma was readily detected as low as 1% fraction. Hence, fluorometric detection of low-abundance EGFR exon 19 deletion mutation using tandem gene amplification may be applicable to clinical diagnosis of NSCLC patients with appropriate TKI treatment.

참고문헌 (Reference)

1 Mohanty J, "Thioflavin T as an efficient inducer and selective fluorescent sensor for the human telomeric g-quadruplex DNA" 135 : 367-376, 2013

2 Zhang Y, "The value of next-generation sequencing for treatment in nonsmall cell lung cancer patients : The observational, real-world evidence in China" 2020 : 9387167-, 2020

3 Herbst RS, "The biology and management of non-small cell lung cancer" 553 : 446-454, 2018

4 Ren XD, "Sensitive detection of low-abundance in-frame deletions in EGFR exon 19 using novel wild-type blockers in real-time PCR" 9 : 8276-, 2019

5 구남인, "Rolling Circle Amplification as Isothermal Gene Amplification in Molecular Diagnostics" 한국바이오칩학회 10 (10): 262-271, 2016

6 Fujita H, "Novel One-Tube-One-Step real-time methodology for rapid transcriptomic biomarker detection : signal amplification by ternary initiation complexes" 88 : 7137-7144, 2016

7 Blanco L, "Highly efficient DNA synthesis by the phage phi 29 DNA polymerase. Symmetrical mode of DNA replication" 264 : 8935-8940, 1989

8 Kim DM, "Fluorometric detection of influenza virus RNA by PCR-coupled rolling circle amplification generating G-quadruplex" 251 : 894-901, 2017

9 Kim DM, "Fluorometric detection of EGFR exon 19 deletion mutation in lung cancer cells using graphene oxide" 143 : 1797-1804, 2018

10 Sharma SV, "Epidermal growth factor receptor mutations in lung cancer" 7 : 169-181, 2007

11 Mitsudomi T, "Epidermal growth factor receptor in relation to tumor development : EGFR gene and cancer" 277 : 301-308, 2010

12 Tokudome N, "Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy" 20 : 103-, 2020

13 Weber B, "Detection of EGFR mutations in plasma and biopsies from nonsmall cell lung cancer patients by allele-specific PCR assays" 14 : 294-, 2014

14 Bae JH, "Comprehensive detection of diverse exon 19 deletion mutations of EGFR in lung cancer by a single probe set" 74 : 849-855, 2015

15 Schwarzenbach H, "Cell-free nucleic acids as biomarkers in cancer patients" 11 : 426-437, 2011

16 Siegel RL, "Cancer Statistics, 2017" 67 : 7-30, 2017

17 Lynch TJ, "Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib" 350 : 2129-2139, 2004

18 Yatabe Y, "A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer" 8 : 335-341, 2006